| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
IN THIS ISSUE
| The first 10% of the full text of this article appears below. |
Arsenic in Drinking Water and Cancer Trends in Chile
Arsenic in drinking water is known to cause several cancers, including bladder and lung cancer. However, the latency period between exposure and cancer onset has not been determined, nor has the extent of the risk increase. Marshall et al. (p. 920) investigated these questions by taking advantage of a unique situation in Chile: one region of the country experienced a dramatic rise in arsenic water concentration beginning in 1958 and a subsequent decline in the 1970s. The authors compared lung and bladder cancer mortality over a 50-year period in
BRCA2 and Risk of Aggressive Prostate Cancer in Iceland
Candidate Oncogene in Human Glioblastoma Multiforme
Antitumor Activity, Deguelin, and Heat Shock Protein 90
AIDS-Related Cancers, CD4 Counts, and Antiretroviral Therapy
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 920-928.
J Natl Cancer Inst 2007 99: 929-935.
J Natl Cancer Inst 2007 99: 949-961.
J Natl Cancer Inst 2007 99: 962-972.
J Natl Cancer Inst 2007 99: 936-948.
J Natl Cancer Inst 2007 99: 906-907.
J Natl Cancer Inst 2007 99: 908-909.